Southwest Autism Research & Resource Center

This study tests whether a liquid form of leucovorin calcium can improve language and reduce core autism symptoms in young children. Researchers will enroll 80 children aged 2.5 to 5 years with autism and language delays. The treatment lasts about 26 weeks, and the main goal is t…

This study looks at whether folinic acid (leucovorin), a drug already used to reduce side effects from chemotherapy, can improve language skills in children with autism spectrum disorder. About 56 children aged 5 to 17 will take the drug for 12 to 24 weeks, and researchers will m…